Meet Our Leadership Team
Best-in-Class Therapies for Immunological and Inflammatory Disorders
Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.
Apogee Therapeutics Launches with $169 Million Apogee Therapeutics Appoints Jane Pritchett Henderson as CFO